D. E. Shaw & Co., Inc. Vbi Vaccines Inc Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.38 - $22.5 $10,261 - $607,590	-27,004 Reduced 55.18%	21,938 $8,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $23.4 $35,727 - $1.15 Million	48,942 New	48,942 $35,000
Q1 2020 May 15, 2020	SELL	$0.73 - $1.91 $15,836 - $41,435	-21,694 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$0.48 - $1.38 $20,767 - $59,705	-43,265 Reduced 66.6%	21,694 $30,000
Q3 2019 Nov 14, 2019	BUY	$0.47 - $1.05 $30,530 - $68,206	64,959 New	64,959 $31,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.